CD79B
Reactivity: Human
FACS
Host: Mouse
Monoclonal
CB3-1
APC
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1.0 mg/mL
Vendel, Calemine-Fenaux, Izrael-Tomasevic, Chauhan, Arnott, Eaton: "B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 3, pp. 1509-17, (2009) (PubMed).
Dornan, Bennett, Chen, Dennis, Eaton, Elkins, French, Go, Jack, Junutula, Koeppen, Lau, McBride, Rawstron, Shi, Yu, Yu, Yue, Zheng, Ebens, Polson: "Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma." in: Blood, Vol. 114, Issue 13, pp. 2721-9, (2009) (PubMed).
Piriou-Guzylack, Salmon: "Membrane markers of the immune cells in swine: an update." in: Veterinary research, Vol. 39, Issue 6, pp. 54, (2008) (PubMed).